Contents

Current Drug Targets, Volume 17 - Number 11


Editorial



Recent Insights into Notch Signaling in Embryonal Rhabdomyosarcoma

, 17(11): 1235 - 1244

Beatrice Conti, Katherine K. Slemmons, Rossella Rota and Corinne M. Linardic


DOI: 10.2174/1389450116666150907105756




Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

, 17(11): 1252 - 1264

Karly C. Sourris, Henry Yao, George Jerums, Mark E.Cooper, Elif I. Ekinci and Melinda T. Coughlan


DOI: 10.2174/1389450116666150722141418




Pharmacological Correction of Cystic Fibrosis: Molecular Mechanisms at the Plasma Membrane to Augment Mutant CFTR Function

, 17(11): 1275 - 1281

Kavisha Arora and Anjaparavanda P. Naren


DOI: 10.2174/1389450117666151209114343





Optimal Sequencing of New Drugs in Metastatic Castration-Resistant Prostate Cancer: Dream or Reality?

, 17(11): 1301 - 1308

Orazio Caffo, Andrea Lunardi, Chiara Trentin, Francesca Maines, Antonello Veccia and Enzo Galligioni


DOI: 10.2174/1389450117666160101121317



Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies

, 17(11): 1309 - 1328

Krishna A. Adeshara, Arundhati G. Diwan and Rashmi S. Tupe


DOI: 10.2174/1389450117666151209124007




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science